HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Seiji Yamamoto Selected Research

NEPP11 compound

10/2009GIF-0173 protects against cerebral infarction through DP1 receptor activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Seiji Yamamoto Research Topics

Disease

26Neoplasms (Cancer)
07/2020 - 08/2002
11Inflammation (Inflammations)
01/2020 - 12/2008
8Sepsis (Septicemia)
05/2012 - 12/2008
7Glioma (Gliomas)
01/2016 - 11/2005
5Insulin Resistance
01/2020 - 10/2009
4Obesity
11/2020 - 01/2017
4Fibrosis (Cirrhosis)
07/2020 - 03/2016
4Carcinoma (Carcinomatosis)
06/2009 - 01/2005
3Stroke (Strokes)
01/2021 - 03/2016
3Hemorrhage
10/2019 - 01/2016
3Ischemia
01/2018 - 11/2003
3Infarction (Infarctions)
02/2012 - 03/2007
3Neoplasm Metastasis (Metastasis)
01/2012 - 10/2004
3Infections
01/2012 - 12/2005
3Brain Neoplasms (Brain Tumor)
12/2009 - 11/2005
3Cerebral Infarction
10/2009 - 09/2004
2Disease Progression
01/2021 - 07/2020
2Vascular Remodeling
11/2020 - 01/2017
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2020 - 11/2005
2Glucose Intolerance
01/2020 - 10/2009
2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2019 - 10/2009
2Carcinogenesis
05/2017 - 03/2006
2Hypoxia (Hypoxemia)
12/2016 - 02/2011
2Glioblastoma (Glioblastoma Multiforme)
01/2016 - 01/2015
2Squamous Cell Carcinoma of Head and Neck
03/2011 - 06/2009
2Brain Ischemia (Cerebral Ischemia)
07/2010 - 10/2009
2Septic Shock (Toxic Shock Syndrome)
01/2010 - 12/2008
2Embolism (Embolus)
03/2007 - 09/2004
2Hearing Loss (Hearing Impairment)
01/2005 - 01/2005
1Cystic Lymphangioma (Hygroma)
11/2021
1Demyelinating Diseases (Demyelinating Disease)
01/2021
1Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked)
01/2021
1Metabolic Diseases (Metabolic Disease)
01/2021
1Lymphedema (Milroy Disease)
07/2020
1Moyamoya Disease (Moya-Moya Disease)
05/2020
1Constipation
01/2020
1Thymoma (Thymic Carcinoma)
01/2020

Drug/Important Bio-Agent (IBA)

5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2018 - 11/2003
5CytokinesIBA
01/2018 - 10/2004
4Glucose (Dextrose)FDA LinkGeneric
01/2020 - 10/2009
4Pharmaceutical PreparationsIBA
10/2019 - 03/2003
3Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
01/2021 - 01/2016
3Fatty Acids (Saturated Fatty Acids)IBA
01/2021 - 03/2016
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2020 - 02/2004
3Platelet-Derived Growth FactorIBA
05/2020 - 01/2016
3Proteins (Proteins, Gene)FDA Link
01/2020 - 12/2008
3Becaplermin (PDGF-BB)FDA Link
05/2018 - 03/2011
3Neuroprotective AgentsIBA
01/2018 - 10/2009
3OligodeoxyribonucleotidesIBA
03/2010 - 10/2004
3Thymidine KinaseIBA
12/2009 - 03/2003
3Ganciclovir (Cytovene)FDA LinkGeneric
12/2009 - 03/2003
3Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
01/2005 - 02/2004
3Interleukin-12 (IL 12)IBA
01/2005 - 10/2004
2Immunoglobulin G (IgG)IBA
01/2021 - 01/2016
2Sirtuin 1IBA
09/2018 - 01/2018
2NestinIBA
05/2018 - 02/2012
2Hematoxylin (Haematoxylon)IBA
01/2018 - 01/2016
2Eosine Yellowish-(YS) (Eosin)IBA
01/2018 - 01/2016
2TamoxifenFDA LinkGeneric
01/2017 - 03/2016
2Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA
01/2017 - 03/2016
2Coloring Agents (Dyes)IBA
01/2016 - 07/2010
2Peptide Hydrolases (Proteases)FDA Link
07/2015 - 01/2010
2Insulin (Novolin)FDA Link
06/2011 - 10/2009
2Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
02/2011 - 12/2008
2NF-kappa B (NF-kB)IBA
03/2010 - 10/2009
2Small Interfering RNA (siRNA)IBA
01/2010 - 08/2005
2SiliconesIBA
03/2007 - 09/2004
21-phenyl-3,3-dimethyltriazene (PDT)IBA
12/2006 - 11/2005
2Cisplatin (Platino)FDA LinkGeneric
08/2005 - 01/2005
2Neoplasm Antigens (Tumor Antigens)IBA
01/2005 - 01/2005
2AntigensIBA
01/2005 - 01/2005
2DNA (Deoxyribonucleic Acid)IBA
02/2004 - 08/2002
1AmphiregulinIBA
11/2021
1Tissue Plasminogen Activator (Alteplase)FDA Link
01/2021
1Collagen Type I (Type I Collagen)IBA
01/2021
1Chemokine CXCL12IBA
11/2020
1Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA
11/2020
1CollagenIBA
07/2020
1Transforming Growth Factor beta (TGF-beta)IBA
07/2020
1AntioxidantsIBA
01/2020
1astaxanthine (astaxanthin)IBA
01/2020
1bofu-tsusho-sanIBA
01/2020
1Phosphotransferases (Kinase)IBA
01/2020
1trichohyalinIBA
01/2020
1lidofenin (HIDA)IBA
11/2019
1tyramine-deoxysorbitolIBA
10/2019

Therapy/Procedure

12Therapeutics
07/2020 - 03/2003
4Punctures
03/2010 - 05/2009
4Ligation
03/2010 - 05/2009
4Radiotherapy
02/2006 - 01/2005
3Drug Therapy (Chemotherapy)
04/2006 - 08/2005
2Immunotherapy
01/2012 - 10/2004
2Intra-Arterial Infusions
03/2011 - 06/2009
2Lasers (Laser)
12/2006 - 11/2005
2Photochemotherapy (Photodynamic Therapy)
12/2006 - 11/2005
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
01/2021
1Thrombolytic Therapy
01/2021
1Occupational Therapy (Therapy, Occupational)
01/2021
1Tissue Expansion
11/2020
1Kampo Medicine (Kampo)
01/2020